294852-99-6 Usage
Triazole derivative
A compound derived from the triazole ring structure, which consists of three nitrogen atoms and 2 carbon atoms, forming a five-membered heterocyclic ring.
Contains two bromine atoms
The presence of two bromine atoms in the compound enhances its reactivity and contributes to its antimicrobial and antifungal properties.
Contains an allyl group
The presence of an allyl group (a propene group) provides the compound with additional reactivity and allows for further functionalization in organic synthesis.
Used as a reagent in organic synthesis
The compound serves as a reagent to facilitate various chemical reactions, particularly in the preparation of pharmaceuticals and agricultural chemicals.
Antimicrobial properties
1-allyl-3,5-dibromo-1H-1,2,4-triazole exhibits the ability to inhibit or kill microorganisms, making it useful in the development of new drugs and pesticides.
Antifungal properties
The compound also demonstrates the ability to prevent or destroy fungi, further contributing to its potential applications in agriculture and medicine.
Potential application in cancer treatment
Researchers have explored the use of 1-allyl-3,5-dibromo-1H-1,2,4-triazole in the treatment of cancer due to its unique chemical structure and reactivity.
Versatile compound
1-allyl-3,5-dibromo-1H-1,2,4-triazole has a wide range of pharmaceutical and agricultural applications, making it a valuable addition to the field of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 294852-99-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,4,8,5 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 294852-99:
(8*2)+(7*9)+(6*4)+(5*8)+(4*5)+(3*2)+(2*9)+(1*9)=196
196 % 10 = 6
So 294852-99-6 is a valid CAS Registry Number.
294852-99-6Relevant academic research and scientific papers
HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE
-
Page/Page column 202, (2019/08/12)
This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.
INHIBITORS OF CYTOMEGALOVIRUS
-
Page/Page column 25, (2015/03/06)
Compounds of Formula (I) wherein n, R1, R1A, R2, R3, Y and Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS
-
Page/Page column 32, (2012/12/13)
The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the mean
1, 2, 4-TRIAZOLE DERIVATIVES AND THEIR ANTI MYCOBACTERIAL ACTIVITY
-
Page/Page column 15, (2011/10/05)
Invention provides antitubercular compounds selected from propargylated 1,2,3 triazoles of Formula I, wherein, X is sulfur(S) or a sulphone (A), n, m represent independently an integer O or 1, with the provision that when 'n' is 1, 'm' is 1; Rl is hydroge
NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS
-
Page/Page column 68, (2011/08/04)
The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma sec
